ROS-Mediated NLRP3 Inflammasome Activation in Brain, Heart, Kidney, and Testis Ischemia/Reperfusion Injury

• Published in: Oxidative medicine and cellular longevity 2016-01, Vol.2016 (2016), p.1-10
• Main Authors: Pisani, Antonina, Trichilo, Vincenzo, Bruschetta, Daniele, Micali, Antonio, Altavilla, Domenica, Crea, Giovanni, Bitto, Alessandra, Arcoraci, Vincenzo, Marini, Herbert, Irrera, Natasha, Rinaldi, Mariagrazia, Puzzolo, Domenico, Minutoli, Letteria, Squadrito, Francesco
• Format: Article
• Language: English
• Subjects: Adapter proteins; Animals; Antioxidants; Apoptosis; Brain - metabolism; Brain - pathology; Cell death; Colleges & universities; Cytokines; Enzymes; Free radicals; Gene expression; Heart; Immune system; Inflammasomes - metabolism; Inflammation; Ischemia; Kidney - metabolism; Kinases; Male; Metabolism; Myocardium - metabolism; NLR Family, Pyrin Domain-Containing 3 Protein - metabolism; Oxidative stress; Physiology; Prevention; Reactive Oxygen Species - metabolism; Reperfusion Injury - metabolism; Reperfusion Injury - pathology; Review; Rodents; Testis - metabolism; Testis - pathology
• ISSN: 1942-0900; 1942-0994
• DOI: 10.1155/2016/2183026

Ischemia and reperfusion (I/R) causes a reduction in arterial blood supply to tissues, followed by the restoration of perfusion and consequent reoxygenation. The reestablishment of blood flow triggers further damage to the ischemic tissue through reactive oxygen species (ROS) accumulation, interference with cellular ion homeostasis, and inflammatory responses to cell death. In normal conditions, ROS mediate important beneficial responses. When their production is prolonged or elevated, harmful events are observed with peculiar cellular changes. In particular, during I/R, ROS stimulate tissue inflammation and induce NLRP3 inflammasome activation. The mechanisms underlying the activation of NLRP3 are several and not completely elucidated. It was recently shown that NLRP3 might sense directly the presence of ROS produced by normal or malfunctioning mitochondria or indirectly by other activators of NLRP3. Aim of the present review is to describe the current knowledge on the role of NLRP3 in some organs (brain, heart, kidney, and testis) after I/R injury, with particular regard to the role played by ROS in its activation. Furthermore, as no specific therapy for the prevention or treatment of the high mortality and morbidity associated with I/R is available, the state of the art of the development of novel therapeutic approaches is illustrated.